Monthly Archives: July 2020
Clinical Outcomes of Acute Pancreatitis in Patients with COVID-19
Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis
Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder. Swallowed topical-acting corticosteroids are effective in bringing active EoE into remission. However, it is not clear if these drugs are effective for long-term maintenance of remission. Continue reading
Collateral Effect of COVID-19 Pandemic on Hospitalizations and Clinical Outcomes in Gastrointestinal and Liver Diseases – A Territory-wide Observational Study in Hong Kong
Loss of Function Mutation in PTPN2 Causes Aberrant Activation of JAK Signaling via STAT and Very Early Onset Intestinal Inflammation
NEW: COVID-19: VUMC workforce exposure, post-infection, and return-to-work guidelines
Exposure is defined as interactions greater than 10 minutes and closer than 6 feet. Look for any new onset of respiratory or flu-like symptoms, including cough, shortness of breath, loss of smell or taste (without other neurologic symptoms), diarrhea,… Continue reading
NEW: Exposure, post-infection and return-to-work FAQs
Answers to, “My coworker tested positive. What do I need to do?” and other questions. Continue reading
NEW: Mask designs are subject to VUMC dress code
Masks are part of the dress code and only certain logos are approved to be worn at VUMC. Continue reading
NEW: Weekly COVID-19 statistics
A snapshot of some of the numbers that help tell the story of COVID-19 at Vanderbilt. Continue reading
Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice
Nonalcoholic fatty liver disease (NAFLD) is the most common pediatric chronic liver disease. Little is known about outcomes in recognized youth. Continue reading
Increased Production of LIGHT by T Cells in Eosinophilic Esophagitis Promotes Differentiation of Esophageal Fibroblasts Toward an Inflammatory Phenotype
Eosinophilic esophagitis (EoE) is an antigen-mediated eosinophilic disease of the esophagus that involves fibroblast activation and progression to fibrostenosis. Cytokines produced by T-helper 2 (Th2) cells and transforming growth factor beta 1 (TGFB1)… Continue reading